The Pharmacy Times® Zoster Resource Center is a comprehensive resource for clinical news and expert insights on the reactivation of the chickenpox virus in the body, which causes a painful rash.
August 26th 2025
A novel shingles vaccine candidate demonstrated positive topline results of antibody and CD4⁺ T cell vaccine responses.
Herpes Zoster Occurs More Frequently in Certain Organ Transplant Recipients
December 10th 2021Although it was previously known that HZ incidence and HZ-related complications occur more frequently and with higher severity in solid organ transplant recipients, numbers varied extensively between studies.
Read More
FDA Approves Expansion of Shingrix for Prevention of Herpes Zoster in Immunocompromised Adults
July 26th 2021Zoster vaccine recombinant, adjuvanted has been approved by the FDA for the prevention of herpes zoster in adults 18 years of age and older who are, or will be, at an increased risk of shingles because of immunodeficiency or immunosuppression.
Read More
Herpes Zoster Associated With Elevated Risk of Stroke, Cerebrovascular Events
July 8th 2021This risk decreased gradually according to age and length of time after an HZ episode, but epidemiological studies and the pathology of VZV vasculopathy both indicate that HZ is a key risk factor for stroke up to 1 year following an HZ episode.
Read More
Intestinal Worm Infection Remotely Worsens Outcomes for Sexually Transmitted Viral Infections
May 7th 2021According to the study, helminth-infected mice developed significantly more severe symptoms after infection with a genital herpes virus (herpes simplex virus), results that the researchers believe are also transferrable to humans.
Read More